BioHealth News
BioBuzz: Growth of Early-Stage Resident Companies Marks the Third Anniversary of Johnson & Johnson Innovation – JLABS @ Washington, DC
In celebration of the three-year anniversary of JLABS @ Washington, DC (JLABS DC), it’s great timing to highlight recent accomplishments and milestones reached by…
Read MoreGeorge Mason researchers lead breakthrough study to find functional cure for HIV
July 25, 2024 / By Laura Powers: Researchers in George Mason University’s Center for Infectious Disease Research (CIDR) and Tulane National Primate Research Center conducted a breakthrough proof-of-concept study,…
Read MoreWashington DC’s 60 Degrees Pharmaceuticals Awarded Contract with U.S. Army for ARAKODA® Supply Chain Upgrade Support
WASHINGTON, July 25, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases,…
Read MoreMaryland Global Consulting Program – Unlocking Your Business’s Global Potential
Ready to take your business to the global stage? Join the Maryland Global Consulting Program through the Robert H. Smith School of Business Center…
Read MoreBioHealth Capital Region Retains #3 Spot in GEN’s Top U.S. Biopharma Clusters for 2024
The BioHealth Capital Region (Maryland, Virginia, and Washington, D.C.) has successfully retained its position as the #3 biopharma cluster in the U.S. for 2024.…
Read MoreMedCityNews: How Startup miRecule Leveraged Its RNA Platform Tech to Land a Sanofi Alliance
RNA therapies developer miRecule is partnered with Sanofi on the development of a treatment for facioscapulohumeral muscular dystrophy, or FSHD. MiRecule, winner in the…
Read MoreMirecule Wins MedCity INVEST 2024 Competition
Chicago, May 2024 — miRecule, a cutting-edge startup focused on developing antibody RNA conjugate therapeutics, clinched the top spot at the prestigious MedCity INVEST…
Read MoreAdventist HealthCare Names BHI Board Member John Sackett President and CEO
Gaithersburg, Md. – Adventist HealthCare has named John Sackett as its next president and CEO, effective Aug. 4, 2024. Sackett has served as Adventist HealthCare’s chief operating…
Read MoreTEDCO Announces SSBCI Investment in Solaxa Inc.
Maryland-based biopharmaceutical company receives funding from TEDCO’s Venture Funds' COLUMBIA, Md., (July 23, 2024) — TEDCO, Maryland’s economic engine for technology companies, announced a recent $500,000…
Read MoreEmbracing Home as a Health Care Hub: FDA’s Virtual Stakeholder Listening Session
On July 25, 2024, the FDA will host a significant virtual public meeting, "Home as a Health Care Hub – Stakeholder Listening Session," from…
Read MorePrecigen Appoints Phil Tennant as Chief Commercial Officer to Spearhead First Potential Gene Therapy Launch
GERMANTOWN, Md., July 23, 2024 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of…
Read MoreEmmes Group partners with Miimansa AI to accelerate adoption of Generative AI in clinical research
ROCKVILLE, Md., July 23, 2024 /PRNewswire/ -- Emmes Group, a leading specialty tech-enabled global contract research organization (CRO), today announced a multi-year strategic partnership…
Read MoreWBJ: JLL experts explore the future and changes of life sciences real estate in D.C.
In the rapidly evolving world of life sciences, the real estate sector is experiencing significant shifts and opportunities. JLL’s latest report, U.S. Life Sciences Property…
Read MoreChildren’s National Innovational District: Closing the ‘Valley of Death’: Pioneering – and paying for – new therapies
With the advent of life-changing cell and gene therapies (CGTs) to treat pediatric diseases, price is becoming a significant obstacle to care and cures.…
Read MoreFDA Rare Disease Innovation Hub to Enhance and Advance Outcomes for Patients
By: Patrizia Cavazzoni, MD, Director, Center for Drug Evaluation and Research and Peter Marks, MD, PhD, Director, Center for Biologics Evaluation and Research An…
Read More